Page last updated: 2024-11-12
copper oxychloride
Description
Research Excerpts
Clinical Trials
Roles
Classes
Pathways
Study Profile
Bioassays
Related Drugs
Related Conditions
Protein Interactions
Research Growth
Market Indicators
Cross-References
| ID Source | ID |
|---|---|
| PubMed CID | 11969527 |
| MeSH ID | M0050100 |
Synonyms (45)
| Synonym |
|---|
| kilex |
| hsdb 5815 |
| dicopper chloride trihydroxide |
| basic copper chloride (cu2cl(oh)3) |
| criscobre |
| copper chloride hydroxide (cu2(oh)3cl) |
| micronutrients tbcc |
| epa pesticide chemical code 008001 |
| natural atacamite, natural paratacamite (gamma) and (beta) |
| rhodiacuivre |
| cuprosana |
| neoram |
| devicopper |
| cuprovinol |
| cupric hydroxide chloride (cu(oh)1,5cl0.5) |
| copper oxychloride (cu2cl(oh)3) |
| copper hydroxide chloride (cu2(oh)3cl) |
| cudrox |
| copper chloride hydroxide |
| chempar |
| cuidrox |
| cuprocaffaro |
| pasta caffaro |
| cop tox |
| tbcc |
| caswell no. 072 |
| aviocaffaro |
| einecs 215-572-9 |
| neoram blu |
| fernacot |
| pere-col |
| aviocaffaro pf |
| copper(ii) oxychloride |
| atacamite |
| 1306-85-0 |
| unii-76712031pg |
| 76712031pg , |
| ec 215-572-9 |
| copper chloride (cu2(oh)3cl) |
| tribasic copper chloride |
| dicopper(ii) chloride trihydroxide |
| cupracol |
| basic cupric oxychloride |
| DTXSID6034475 |
| Q2647468 |
Research Excerpts
Bioavailability
| Excerpt | Reference | Relevance |
|---|---|---|
| " Linear regression over nonzero dietary levels of log10 transformed liver Cu concentration (parts per million of DM) on analyzed total Cu intake (micrograms) resulted in a slope ratio estimate of 106+/-19 for bioavailability of Cu from TBCC compared to 100 for that in Cu sulfate." | ( The effect of dietary supplementation with copper sulfate or tribasic copper chloride on broiler performance, relative copper bioavailability, and dietary prooxidant activity. Ammerman, CB; Henry, PR; Luo, XG; Miles, RD; O'Keefe, SF, 1998) | 0.3 |
| "8) for bioavailability of copper from TBCC compared with 100 for that in copper sulfate." | ( Effects of dietary supplementation with copper sulfate or tribasic copper chloride on broiler performance, relative copper bioavailability, and oxidation stability of vitamin E in feed. Ji, F; Lin, YX; Liu, B; Lu, L; Luo, XG; Steward, FA; Yu, SX, 2005) | 0.33 |
| " Compared with CuSO4 (100%), relative bioavailability values of TBCC were 104 and 104%, based on serum ceruloplasmin and liver copper, respectively, and relative bioavailability values of CuMet were 130 and 111%." | ( Copper bioavailability, blood parameters, and nutrient balance in mink. Gao, XH; Guo, JG; Liu, Z; Wu, XZ; Yang, FH; Zhang, TT, 2015) | 0.42 |
| "This experiment was conducted to determine the relative bioavailability (RBV) of Cu in tribasic copper chloride (TBCC) to Cu in copper sulfate (monohydrate form; CuSO4·H2O) for layer diets based on egg yolk and feather Cu concentrations." | ( Relative bioavailability of copper in tribasic copper chloride to copper in copper sulfate for laying hens based on egg yolk and feather copper concentrations. Kil, DY; Kim, JH; Kim, JW; Shin, JE, 2016) | 0.43 |
[information is derived through text-mining from research data collected from National Library of Medicine (NLM), extracted Dec-2023]
Research
Studies (32)
| Timeframe | Studies, This Drug (%) | All Drugs % |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 1 (3.13) | 18.2507 |
| 2000's | 9 (28.13) | 29.6817 |
| 2010's | 16 (50.00) | 24.3611 |
| 2020's | 6 (18.75) | 2.80 |
| [information is prepared from research data collected from National Library of Medicine (NLM), extracted Dec-2023] | ||
Market Indicators
Research Demand Index: 45.20
According to the monthly volume, diversity, and competition of internet searches for this compound, as well the volume and growth of publications, there is estimated to be strong demand-to-supply ratio for research on this compound.
| This Compound (45.20) All Compounds (24.57) |
Study Types
| Publication Type | This drug (%) | All Drugs (%) |
|---|---|---|
| Trials | 5 (15.63%) | 5.53% |
| Reviews | 0 (0.00%) | 6.00% |
| Case Studies | 0 (0.00%) | 4.05% |
| Observational | 0 (0.00%) | 0.25% |
| Other | 27 (84.38%) | 84.16% |
| [information is prepared from research data collected from National Library of Medicine (NLM), extracted Dec-2023] | ||